|
|
Emerging imaging technologies for automated analyses of calcineurin-dependent brain function |
| 3R01GM136906-03S1 |
|
NIGMS |
2022 |
|
|
Quantitative 3D imaging of in situ nanoparticle movement and cellular behavior during neuroinflammation |
| 3R35GM124677-06S1 |
|
NIGMS |
2022 |
|
|
Cellular mechanisms for age-related cognitive dysfunction and its pharmacological reversal: a strategy towards prevention and treatment of postoperative cognitive deficits in elderly patients |
| 5R01GM128183-04 |
|
NIGMS |
2022 |
|
|
Emerging imaging technologies for automated analyses of calcineurin-dependent brain function |
| 5R01GM136906-03 |
|
NIGMS |
2022 |
|
|
Quantitative 3D imaging of in situ nanoparticle movement and cellular behavior during neuroinflammation |
| 5R35GM124677-06 |
|
NIGMS |
2022 |
|
|
Emerging imaging technologies for automated analyses of calcineurin-dependent brain function |
| 1 R01 GM136906-01A1 |
CRETON, ROBBERT J |
NIGMS |
2020 |
|
|
CELLULAR MECHANISMS FOR AGE-RELATED COGNITIVE DYSFUNCTION AND ITS PHARMACOLOGICAL REVERSAL: A STRATEGY TOWARDS PREVENTION AND TREATMENT OF POSTOPERATIVE COGNITIVE DEFICITS IN ELDERLY PATIENTS |
| 1R01GM128183-01A1 |
RUDOLPH, UWE |
NIGMS |
2019 |
|
|
SELECTIVE INHIBITION OF NITRIC OXIDE SYNTHASE FOR MULTIPLE INDICATIONS |
| 1R35GM131788-01 |
SILVERMAN, RICHARD B |
NIGMS |
2019 |
|
|
A SCALABLE OPTOGENETIC SYSTEM OF FOCAL STROKE INDUCTION IN ZEBRAFISH FOR TESTING STROKE DISPARITY GENES |
| 1SC3GM132058-01 |
LEE, JU-AHNG |
NIGMS |
2019 |
|
|
DEVELOPING NOVEL ALZHEIMER'S DISEASE RNA THERAPEUTICS CROSSING THE BLOOD-BRAIN BARRIER |
| 3P30GM122732-03S1 |
CHEN, QIAN |
NIGMS |
2019 |
